The baby in the woman’s belly who died from complications from a newborn cough medicine is the third pregnant woman in the world to die of complications from it, a U.K. study says.
Baby cough medicine (CIM) was given to the pregnant woman at the U.S. Embassy in London, U.N. experts said Wednesday, after a woman in Japan died in January from complications after being given it.
The baby in question, a newborn boy, was found on Jan. 8 at the United Kingdom’s Embassy in Japan.
The infant died in the hospital on Feb. 7.
Doctors at the Japanese Embassy in Beijing said Wednesday that they had received information that the infant had been given a new CIM injection on Feb 11.
The Japanese Embassy has said that no cases of newborns dying from CIM have been reported in Japan since 2013, but the new report indicates that it is possible the baby may have been injected in Japan before the Embassy notified the WHO.
U.S.-based physician Richard Cavanagh said the baby’s death raised questions about the safety of CIM injections.
“There is no evidence to suggest that CIM is safe, he said in an email to The Associated Press.”
The new report suggests that the woman had been exposed to the CIM before being sent to the Embassy,” Cavanah said.”
It also raises questions about how the infant got in contact with the patient.
“U.N.’s International Committee of the Red Cross says the death could have been prevented had the embassy notified the World Health Organization.
The woman who died had been admitted to the hospital in the early stages of labor and was delivered via caesarean section, according to a WHO report on the case.
She died in her 20s, but her condition was later described as stable.
The WHO has since sent a team to Japan to investigate and said that a blood sample collected on Feb 10 showed that the newborn boy had a high-risk genetic mutation in the gene that causes the disease, known as the Rhesus 1A gene.
The mutation can cause the baby to develop a fever and diarrhea, according the WHO report.
Cavanagh says it is important that the Japanese government, which is responsible for providing health care to foreigners in Japan, makes sure that their health care is available to the infants.”
If the baby has a mutation in this gene, we must make sure that the baby is not exposed to it,” he said.
Embassy said in a statement that it was working with Japan’s health authorities to “develop appropriate measures” to address concerns about the health of the baby and to “ensure the health and safety of all of our personnel working in Japan.”
A U.n. official says the baby was in the belly of a woman at a hospital in Tokyo.
The baby died in a hospital on Jan 8.
The child had been in the stomach of a baby, the official said.
(AP Photo/Koji Sasahara)The infant, who was not identified by his father, was in a newborn nursery at the embassy.
It is not known if the baby had any siblings, according an embassy statement.
Doctors say it is not uncommon for babies to be given CIM.
The World Health Organisation has estimated that one in four infants born in developing countries will develop the virus.
The virus causes severe acute respiratory symptoms and can cause pneumonia, pneumonia and death.